DB05364ExperimentalSmall molecule
ROX-888 is ROXRO's lead compound which is currently in Phase 3 trials for the treatment of acute pain, including post-operative pain.
- Mechanism
- Curator reviewed
ROX-888 is a intranasal formulation of the broadly used injectible analgesic, ketorolac. It has ability to provide effective analgesia in acute medical conditions resulting in moderate-severe pain, without the disabling side effects of opioid analgesics
- Primary indication
- Investigated for use/treatment in pain (acute or chronic).Curator reviewed
- Code names
- ROX-888
Resolves to
Targets
What you can answer from here — as of April 02, 2025
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with ROX-888, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account